Experts highlighted how robotic-assisted procedures are improving surgical precision, reducing complications, and enabling faster recovery
Move to accelerate cancer care expansion across India
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
The launch saw the presence of senior clinicians and leadership from the Manipal Hospitals network
The FDA is also reviewing the application under its Real-Time Oncology Review (RTOR) program and Project Orbis
The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care
The event showcased latest breakthroughs in minimally invasive surgery, organ-preservation strategies, and targeted therapies
Backed by a £680,000 grant from Leeds Hospitals Charity, the study is jointly led by academics and clinicians from the University of Leeds and Leeds Teaching Hospitals NHS Trust
Subscribe To Our Newsletter & Stay Updated
